Leo Pharma loses US region CEO – interim replacement found in current CFO

The dermatology firm Leo Pharma has a CEO hunt ahead, as the man currently in charge of its US operations has been poached by Cara Therapeutics. Until a replacement has been found, Leo Pharma's current CFO will take the reigns in the US.

Photo: Leo Pharma / PR

Leo Pharma is waving goodbye to its former CEO of its US operations, Christopher Posner. Posner has left the company to join the US-listed biotech business Cara Therapeutics, where he has sat on the board.

In a mail sent to MedWatch, Leo Pharma expresses its full understanding of Posner's choice to follow his new career opportunity.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs